Cover Image
市場調查報告書

中國的血液透析機產業

Research Report on Hemodialysis Industry in China, 2011-2020

出版商 China Research and Intelligence 商品編碼 312870
出版日期 內容資訊 英文 60 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的血液透析機產業 Research Report on Hemodialysis Industry in China, 2011-2020
出版日期: 2016年06月01日 內容資訊: 英文 60 Pages
簡介

中國隨著經濟發展和平均每人所得的增加、血液透析機費用支付能力的提高,預計血液透析機產業急速擴大,預計年複合成長率超越20%,市場規模至2020年達到700億元。

本報告提供中國的血液透析機產業詳查、血液透析機市場現狀、左右該市場成長的經濟環境與政策環境、設備及藥物的供給企業、推動市場成長要素、詳細分析以及市場競爭情形、今後的市場預測。還有提供主要企業包含經營情形分析的詳細企業簡介,再加上這個產業上開發及投資相關的建議。

第1章 血液透析機產業概要

  • 定義
  • 血液透析機設備
  • 血液透析機用藥物
  • 血液透析機服務
  • 產業鏈

第2章 血液透析機全球市場分析

  • 透析群組
  • 血液透析機的覆蓋率
  • 血液透析機設備市場
  • 血液透析機服務市場

第3章 中國的血液透析機產業的發展環境

  • 經濟環境
    • 中國的GDP擴大情形
    • 中國的平均每人所得的增加情形
  • 政策環境
    • 產業政策
    • 醫療保險政策

第4章 中國的血液透析機產業的經營情形

  • 末期腎功能衰竭患者
    • 末期腎功能衰竭患者所必須的需求數量
    • 使用血液透析機的末期腎功能衰竭患者的實數
  • 血液透析機設備
    • 人工透析設備市場規模
    • 血液透析設備市場規模
  • 血液透析機用藥物及服務市場
    • 藥物及服務成本比率
    • 血液透析機用藥物及服務的市場規模
  • 中國的血液透析機產業的總市場規模

第5章 中國的血液透析機產業的市場競爭情形

  • 進入障礙
    • 政策的障礙
    • 資金的障礙
    • 技術性障礙
  • 產業的市場競爭結構
    • 原料供給企業
    • 客人處企業、客戶
    • 產業企業間的競爭
    • 新加入企業
    • 企業交替

第6章 中國的血液透析機設備及藥物的進出口分析

  • 進口分析
    • 透析設備的進口情形
    • 透析管線的進口情形
    • 血液透析機液的進口情形
  • 出口分析
    • 透析設備的出口情形
    • 透析管線的出口情形
    • 血液透析機液的出口情形

第7章 中國的血液透析機市場主要企業

  • Fresenius SE & Co. KGaA
  • Nipro株式會社
  • Baxter International
  • 旭化成株式會社
  • Weigao Group
  • Huaren Pharmaceutical Co., Ltd.
  • Guangdong Biolight Meditech Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Jihua Medical Apparatus and Instruments Co., Ltd.
  • Bain Medical Equipment (Guangzhou) Co., Ltd.

第8章 中國的血液透析機產業預測

  • 產業發展的影響因素
    • 宏觀經濟
    • 政府對策
    • 市場供需
  • 供給預測
    • 血液透析機設備供給數量預測
    • 血液透析機用藥物及服務供給數量預測
  • 需求預測
    • 市場規模預測
    • 各領域需求預測
  • 開發及投資相關的建議
    • 關於投資機會
    • 開發建議

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 1606348

Chronic kidney disease (CKD), namely chronic renal insufficiency or chronic renal failure, refers to chronic kidney structure and function disorder caused by various factors. According to GFR (Glomerular filtration rate) index, chronic kidney disease is divided into five stages. Once the CKD patients enter the fifth stage, namely end-stage renal disease (ESRD) commonly known as uremia, and the renal replacement therapy must be conducted.

Hemodialysis (HD) is one of the renal replacement therapy ways to treat acute or chronic renal failure patients. Presently, there are more than 2 million end-stage renal disease (ESRD) patients all over the world who choose the dialysis therapy, and about 90% of them receive hemodialysis. Because of the high hemodialysis expenses, the dialysis patients mainly concentrate in developed countries. ESRD patients on dialysis account for 10%-20% in developing countries, which is far lower than the 80% in developed countries. The population of dialysis patients is relatively small but fast-growing. In recent years, the annual growth rate of dialysis patients reached over 10% in China, India and Brazil, which was much higher compared to 3%-5% in developed countries.

With the increasing dialysis patients, the number of the global dialysis centers is correspondingly growing, of which the growth rate is consistent with that of dialysis patients. In 2015, the global dialysis centers were estimated to reach 38,000. On average, every dialysis center provided services to 70-80 patients. Based on the relatively high dialysis rate and the slow increase of dialysis patients, it is predicted that the new hemodialysis centers will be constructed in emerging markets of Asia-Pacific regions especially China. Presently, there are a large number of unsatisfied requirements, which will be the significant points of the future dialysis market.

Up to the end of 2015, China had the population of more than 1.37 billion, and ESRD patients surpassed 2 million. Unable to afford it, only a small proportion of end-stage renal disease patients can receive the dialysis therapy. There were 300,000 dialysis patients in China by the end of 2015. The overall dialysis treatment rate was estimated to reach 14%-15% in China, which was lower than the average global level of 38%-40%. It was far lower than the above 90% treatment rate in developed countries. Therefore, there were large development potentials in Chinese dialysis market.

With the improvement of Chinese medical care as well as the increasing income and payment ability of hemodialysis patients, the hemodialysis industry will develop rapidly in the future. Hemodialysis services mainly consist of dialyzers, dialysis consumables, dialysis drugs and labor services. Hemodialysis instruments include dialysis machines, dialyzers and dialysis pipelines. Dialyzers are core consumables with high technical barriers, which accounts for the largest market share. The market size in China exceeded CNY 5 billion while the domestic market share was approximately 30% in 2015. The market size of China's dialysis machines reached about CNY 3 billion in 2015, and the foreign capital brands accounted for 80% of the market share. The hemodialysis powder and fluid are important solvents in the process of hemodialysis. In spite of relatively low technical barriers, domestic enterprises account for over 90% of the market share thanks to the high transport cost (The reasonable transportation radius is no larger than 800 km) and policy barriers. In addition, the market competition is not fierce. Conventional hemodialysis medicines include EPO and heparin which are in general domestically produced. Service costs include costs of bed and health care labors.

Presently, the average hemodialysis expense is about 400-500 CNY for each treatment in China. The gross profit rate of hemodialysis business can universally reach 30-40% or higher. Charges in public hospitals are generally higher than those of private hospitals, of which the gross profits can reach above 50%. According to CRI, there were about 4,000 hemodialysis centers in China up to the end of 2015.

In 2015, the hemodialysis market size exceeded CNY 20 billion with an increase of more than 15% in recent years. The global ESRD patients receiving hemodialysis treatment are estimated to reach 4 million, and those in China will surpass 600,000 accounting for 15%. It is predicted that the overall market size of hemodialysis industry will increase to over CNY 50 billion by 2020.

Through this report, the readers shall acquire the following information:

  • Factors Influencing the Development of Hemodialysis Industry in China
  • Analysis of Hemodialysis Industry Chain in China
  • Analysis of Supply and Demand in China's Hemodialysis Industry
  • Key Enterprises in China's Hemodialysis Industry
  • Market Competition Status in China's Hemodialysis Industry
  • Driving Factors for Development of China's Hemodialysis Market
  • Forecast on Development of China's Hemodialysis Market

The Following Enterprises and People Are Recommended to Purchase This Report:

  • Medical Institutions
  • Manufacturers of Medical Equipment and Drugs
  • Investors and Research Institutions Concerned about Hemodialysis Industry

Table of Contents

1. Related Concepts of Hemodialysis Industry

  • 1.1. Definition
  • 1.2. Hemodialysis Equipment
    • 1.2.1. Hemodialysis Machine
    • 1.2.2. Water Treatment System
    • 1.2.3. Dialyzer
  • 1.3. Hemodialysis Drugs
    • 1.3.1. Hemodialysis Fluid
    • 1.3.2. Antianemia Drugs
    • 1.3.3. Anticoagulant
  • 1.4. Hemodialysis Services

2. Analysis and Forecast of Global Hemodialysis Market

  • 2.1. Dialysis Group
  • 2.2. Coverage Rate of Hemodialysis
  • 2.3. Hemodialysis Equipment Market
  • 2.4. Hemodialysis Service Market

3. Development Environment of Hemodialysis Industry in China, 2011-2020

  • 3.1. Economic Environment
    • 3.1.1. Macro Economy
    • 3.1.2. Resident Income
    • 3.1.3. Medical Industry
  • 3.2. Policy Environment
    • 3.2.1. Industry Policies
    • 3.2.2. Medicare Policies

4. Operation Status of Hemodialysis Industry in China, 2011-2015

  • 4.1. Analysis on Demand
    • 4.1.1. Demand Volume of ESRD Patients
    • 4.1.2. Actual Number of ESRD Patients Receiving Hemodialysis
  • 4.2. Market Size of Hemodialysis Equipment in China, 2011-2015
    • 4.2.1. Market Size of Dialyzers
    • 4.2.2. Market Size of Hemodialysis Machines
  • 4.3. Market Size of Hemodialysis Drugs and Services
    • 4.3.1. Analysis on Costs of Drugs and Services
    • 4.3.2. Market Size of Hemodialysis Drugs

5. Competition Status of Hemodialysis Industry in China, 2011-2016

  • 5.1. Barriers to Entry
    • 5.1.1. Policy Barriers
    • 5.1.2. Capital Barriers
    • 5.1.3. Technical Barriers
  • 5.2. Competition Structure of the Industry
    • 5.2.1. Upstream Suppliers
    • 5.2.2. Downstream Customers
    • 5.2.3. Competition among Enterprises inner the Industry
    • 5.2.4. New Entrants
    • 5.2.5. Substitutes

6. Analysis on Import and Export of Hemodialysis Equipment and Drugs in China, 2011-2015

  • 6.1. Analysis of Import
    • 6.1.1. Import of Dialyzers
    • 6.1.2. Import of Dialysis Tubing
    • 6.1.3. Import of Hemodialysis Fluid
  • 6.2. Analysis of Export
    • 6.2.1. Export of Dialyzers
    • 6.2.2. Export of Dialysis Pipelines
    • 6.2.3. Export of Hemodialysis Fluid

7. Key Enterprises in Hemodialysis industry, 2011-2016

  • 7.1. Fresenius Medical Care
    • 7.1.1. Enterprise Profile
    • 7.1.2. Analysis of Operation Status
  • 7.2. NIPRO Medical Corporation
    • 7.2.1. Enterprise Profile
    • 7.2.2. Analysis of Operation Status
  • 7.3. Baxter International Inc.
    • 7.3.1. Enterprise Profile
    • 7.3.2. Analysis of Operation Status
  • 7.4. Asahi Kasei Medical Co., Ltd.
    • 7.4.1. Enterprise Profile
    • 7.4.2. Analysis of Operation Status
  • 7.5. Shandong Weigao Group Medical Polymer Co., Ltd.

7. 5.1. Enterprise Profile

    • 7.5.2. Analysis of Operation Status
  • 7.6. SWS Hemodialysis Care Co., Ltd.
  • 7.7. Guangdong Biolight Meditech Co., Ltd.
  • 7.8. Sichuan Kelun Pharamceutical Co., Ltd.
  • 7.9. Jihua Medical Apparatus & Instruments Co., Ltd. Guangzhou
  • 7.10. Bain Medical Equipment (Guangzhou) Co., Ltd.
  • 7.11. Zhuhai Hokai Medical Instruments Co., Ltd.

8. Prospect of Hemodialysis Industry in China, 2016-2020

  • 8.1. Factors Influencing Development
    • 8.1.1. Macro Economy
    • 8.1.2. Government Policies
    • 8.1.3. Major Driving Forces
  • 8.2. Forecast on Supply
    • 8.2.1. Forecast on Supply of Hemodialysis Equipment
    • 8.2.2. Forecast on Supply of Hemodialysis Drugs and Services
  • 8.3. Prediction on Demand
    • 8.3.1. Prediction on Market Size
    • 8.3.2. Forecast on Demand in Niche Markets
  • 8.4. Recommendations on Development and Investment
    • 8.4.1. Investment Opportunities
    • 8.4.2. Development Proposals

Selected Charts

  • Chart Estimation of ESRD Dialysis Treatment Rate in Different Countries
  • Chart Global Market Pattern of Dialysis Equipment, 2015
  • Chart Total Medical Expenses in China, 2006-2015
  • Chart Market Size of Hemodialysis Services in China, 2011-2015
  • Chart Market Size of Hemodialyzers in China, 2011-2015
  • Chart Market Size of Hemodialysis Drugs in China, 2011-2015
  • Chart Import Status of Renal Dialysis Equipment in China, 2011-2015
  • Chart Export Status of Renal Dialysis Equipment in China, 2011-2015
  • Chart Operation Status of Fresenius Medical Care, 2011-2015
  • Chart Operation Status of NIPRO Medical Corporation, 2011-2015
  • Chart Operation Status of Shandong Weigao Group Medical Polymer Co., Ltd., 2011-2015
  • Chart Operation Status of Guangdong Biolight Meditech Co., Ltd., 2011-2015
  • Chart Output Volume of Hemodialysis Related Products in Guangdong Biolight Meditech Co., Ltd., 2013-2015
  • Chart Prediction on Market Size of Hemodialysis Services in China, 2016-2020
  • Chart Prediction on Market Size of Hemodialysis Drugs in China, 2016-2020
Back to Top